Mr. Lousararian is CEO of Verax BioMedical, which has developed technology for the detection of bacterial contamination in cells and tissue. He was previously founder & CEO of Angiolink, maker of cardiovascular closure devices which was acquired by Medtronic in 2004. Prior to Angiolink he served as COO of medical device manufacturer STD, VP and business unit manager of Thermo ReTec, and Assoc. General Counsel of Thermo Electron. Earlier in his career, Mr. Lousararian was an attorney at Hale and Dorr. Mr. Lousararian received his JD from the University of Chicago and his BA from the University of Massachusetts.